AdvanCell, Lilly partner on new targeted alpha therapies for cancer treatment

AdvanCell, Lilly partner on new targeted alpha therapies for cancer treatment

Source: 
Pharmaceutical Business Review
snippet: 

Radiopharmaceutical company AdvanCell has expanded its partnership with Eli Lilly and Company to advance targeted alpha therapies for the treatment of cancer.